| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 564.1 | 529.9 | 460.2 |
| Other income | 12.6 | 10.5 | 15.4 |
| Total income | 576.7 | 540.4 | 475.6 |
| Profit before exceptional items & tax | 75.3 | 64.8 | 61.0 |
| Exceptional items | 1.3 | 0.0 | -2.5 |
| Profit before tax | 76.6 | 64.8 | 58.5 |
| Net profit | 50.0 | 43.6 | 42.5 |
| Operating margin | 13.3% | 12.0% | 12.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +17.60% |
|---|---|
| Net profit, quarter on quarter | +14.70% |
| Revenue, year on year | +22.60% |
BSE results filing, NSE: AGARWALEYE. Figures extracted from the filing.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹500.00
- Market cap
- ₹15,851 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 106.8×Sector 57.8×
- Promoter holding
- 32.34%-0.02% QoQ
- FII holding
- 57.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Annual General Meeting
Dr. Agarwal's Health Care Limited held its 16th AGM on September 21, 2026. Shareholders approved all agenda items, including financial statements and director re-appointments.
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Dr. Agarwal’s reported strong Q1FY27 results with revenue of ₹614 Cr and EBITDA of ₹177 Cr. Strategy focuses on aggressive 'Greenfield' expansion and hub-and-spoke scalability across India and Africa.
Dr. Agarwals Health Care Q1 FY27 Results: Net Profit ₹55 Cr, Up 44.4% YoY
Dr. Agarwals Health Care Ltd reported revenue from operations of ₹614 Cr (+26.0% YoY) and net profit of ₹55 Cr (+44.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹55 Cr · +44.4% YoY
Dr. Agarwals Health Care Earnings Call: Key Takeaways
Dr. Agarwal’s reported strong FY26 performance, crossing INR 2,000cr revenue milestone with significant network expansion and EBITDA margin improvement to 28.9%.
Dr. Agarwals Health Care Earnings Call: Key Takeaways
Dr. Agarwals reported 21% income growth in FY26, driven by aggressive network expansion (57 new facilities) and clinical excellence.